Affiliation:
1. Department of Internal Medicine and Clinical Immunology, Referral Center for Adult Autoimmune Cytopenia (CeReCAI) Dijon University Hospital Dijon France
2. Department of Pediatrics Weill Cornell Medical College New York New York USA
Abstract
Immune thrombocytopenia (ITP) is an autoimmune bleeding disorder characterized by isolated thrombocytopenia. Its pathogenesis is complex relying in large part on destruction of platelets recognized by autoantibodies within the spleen. However, other mechanisms, such as platelet desialylation, may play a role in platelet reduction by accelerating their clearance in the liver. In their study, Mendoza and colleagues reported on platelet scintigraphy performed in 51 ITP patients, showing a response in 87.5% when the sequestration occurred in the spleen versus 45% in case of non‐splenic destruction. Platelet desialylation was also measured after splenectomy and found to be higher in non‐responder patients. These latter results, while requiring confirmation prior to splenectomy, support platelet desialylation may also be a potential biomarker of non‐response to splenectomy.Commentary on: Mendoza et al. Study of platelet kinetics in immune thrombocytopenia to predict splenectomy response. Br J Haematol 2024;204:315–323.